date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-17-18,"They tackled chronic cough. Now with $54.5 million, this duo is targeting Alzheimer's and more",American City Business Journals
Oct-17-18,Merck Announces Appointment of Jim Scholefield as Chief Information and Digital Officer,Business Wire
Oct-17-18,5 Blue Chip Drug Stocks Poised for Long-Term Gains,Investopedia
Oct-18-18,Jim Scholefield Leaves Nike for Top Tech and Digital Job at Merck,The Wall Street Journal
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-19-18,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Oct-19-18,2 Dow Safety Stock for Volatile Market: Portfolio Manager,Investopedia
Oct-19-18,"Top Stock Reports for UPS, Merck & BHP Billiton",Zacks
Oct-19-18,Why Merck's Latest Success Means Trouble for Exelixis Inc.,Motley Fool
Oct-19-18,"Today's Research Reports on Trending Tickers: Merck & Co., and Bristol-Myers Squibb",ACCESSWIRE
Oct-22-18,Why Aduro Biotech Crashed 29.5% Today,Motley Fool
Oct-22-18,"Why Tesaro, Inc. Is Tanking Today",Motley Fool
Oct-22-18,Here's Why Clovis Oncology Dropped as Much as 21.2% Today,Motley Fool
Oct-22-18,Here's Why ImmunoGen Fell Today,Motley Fool
Oct-22-18,Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug,MarketWatch
Oct-22-18,"Mercks KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival Compared to Standard of Care, as Monotherapy and in Combination with Chemotherapy, as First-Line Treatment for Patients with Recurrent or Metastatic Head and Neck Cancer",Business Wire
Oct-22-18,Merck (MRK) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-22-18,Strong Earnings Enough Reason to Stay Long JNJ Stock,InvestorPlace
Oct-24-18,Merck's Q3 Earnings Preview,Benzinga
Oct-25-18,Dow Closes 400 Points Higher as Wall Street Rebounds on Earnings,TheStreet.com
Oct-25-18,Edited Transcript of MRK earnings conference call or presentation 25-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-25-18,"Merck & Co., Inc. -- Moody's: Merck's shareholder payouts credit negative",Moody's
Oct-25-18,"Pharma Giants Merck, Bristol Diverge On Earnings Beat As Sales Lag",Investor's Business Daily
Oct-25-18,Merck & Co Inc (MRK) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-25-18,Merck and Bristol-Myers Squibb Are Seeing Rising Sales of Their Cancer Drugs,Barrons.com
Oct-25-18,"Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View",Zacks
Oct-25-18,Former P&Ger joins Merck C-suite,American City Business Journals
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,Merck posts global sales of $11B in third quarter,Associated Press
Oct-25-18,"Merck&Co Earnings beat, Revenue misses In Q3",Investing.com
Oct-25-18,J&J Intends to Buy Residual Stake in Japanese Skincare Firm,Zacks
Oct-25-18,Merck says to retain animal health business as part of company,Reuters
Oct-25-18,3 Beaten-Down Biotech Stocks: Can They Bounce Back?,Motley Fool
Oct-25-18,"Cancer drug Keytruda powers Merck's profit beat, forecast raise",Reuters
Oct-25-18,Merck (MRK) Q3 Earnings Surpass Estimates,Zacks
Oct-25-18,[$$] Merck's 3Q Profit Misses Expectations,The Wall Street Journal
Oct-25-18,Drugmaker Merck beats profit estimate on Keytruda strength,Reuters
Oct-25-18,[$$] Bristol-Myers Squibb Raises Full-Year Profit Forecast,The Wall Street Journal
Oct-25-18,Bristol-Myers profit rises on better-than-expected cancer drug sales,Reuters
Oct-25-18,"Merck raises quarterly dividend by 15% to 55 cents a share, unveils $10 billion buyback",MarketWatch
Oct-25-18,Merck reports third-quarter profit vs year-ago loss,Reuters
Oct-25-18,Merck Announces Increased Fourth-Quarter Dividend and $10 Billion Share Repurchase Authorization,Business Wire
Oct-25-18,Merck Announces Third-Quarter 2018 Financial Results,Business Wire
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"Company News For Oct 26, 2018",Zacks
Oct-26-18,Edited Transcript of MRK earnings conference call or presentation 25-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
